Toxicity screenings of nanomaterials: challenges due to interference with assay processes and components of classic in vitro tests

Abstract Given the multiplicity of nanoparticles (NPs), there is a requirement to develop screening strategies to evaluate their toxicity. Within the EU-funded FP7 NanoTEST project, a panel of medically relevant NPs has been used to develop alternative testing strategies of NPs used in medical diagnostics. As conventional toxicity tests cannot necessarily be directly applied to NPs in the same manner as for soluble chemicals and drugs, we determined the extent of interference of NPs with each assay process and components. In this study, we fully characterized the panel of NP suspensions used in this project (poly(lactic-co-glycolic acid)–polyethylene oxide [PLGA–PEO], TiO2, SiO2, and uncoated and oleic-acid coated Fe3O4) and showed that many NP characteristics (composition, size, coatings, and agglomeration) interfere with a range of in vitro cytotoxicity assays (WST-1, MTT, lactate dehydrogenase, neutral red, propidium iodide, 3H-thymidine incorporation, and cell counting), pro-inflammatory response evaluation (ELISA for GM-CSF, IL-6, and IL-8), and oxidative stress detection (monoBromoBimane, dichlorofluorescein, and NO assays). Interferences were assay specific as well as NP specific. We propose how to integrate and avoid interference with testing systems as a first step of a screening strategy for biomedical NPs.

[1]  Julie W. Fitzpatrick,et al.  Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy , 2005, Particle and Fibre Toxicology.

[2]  D. Warheit,et al.  Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. , 2008, Pharmacology & therapeutics.

[3]  P. M. Williams,et al.  Confounding experimental considerations in nanogenotoxicology. , 2009, Mutagenesis.

[4]  R. Aitken,et al.  Manufacture and use of nanomaterials: current status in the UK and global trends. , 2006, Occupational medicine.

[5]  M. Saunders,et al.  The toxicity, transport and uptake of nanoparticles in the in vitro BeWo b30 placental cell barrier model used within NanoTEST , 2015, Nanotoxicology.

[6]  Verena Wilhelmi,et al.  Evaluation of apoptosis induced by nanoparticles and fine particles in RAW 264.7 macrophages: facts and artefacts. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  Yin-Sheng Ma,et al.  Interaction of nano-TiO2 with lysozyme: insights into the enzyme toxicity of nanosized particles , 2010, Environmental science and pollution research international.

[8]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[9]  N. Monteiro-Riviere,et al.  Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. , 2009, Toxicology and applied pharmacology.

[10]  Bengt-Harald Jonsson,et al.  Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[11]  R Damoiseaux,et al.  No time to lose--high throughput screening to assess nanomaterial safety. , 2011, Nanoscale.

[12]  A. Chaffotte,et al.  Carbon black nanoparticles impair acetylation of aromatic amine carcinogens through inactivation of arylamine N-acetyltransferase enzymes. , 2011, ACS nano.

[13]  Alexandra Kroll,et al.  Current in vitro methods in nanoparticle risk assessment: limitations and challenges. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[14]  R. Hamel,et al.  Carbon black and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial cells: Need for multiparametric evaluation due to adsorption artifacts , 2009, Inhalation toxicology.

[15]  A. Chesson,et al.  The Potential Risks Arising from Nanoscience and Nanotechnologies on Food and Feed Safety 1 Scientific Opinion of the Scientific Committee , 2009 .

[16]  M. Marinovich,et al.  Risk Assessment of Products of Nanotechnologies , 2009 .

[17]  Shareen H. Doak,et al.  Dextran Coated Ultrafine Superparamagnetic Iron Oxide Nanoparticles: Compatibility with Common Fluorometric and Colorimetric Dyes , 2011, Analytical chemistry.

[18]  Alexandra Kroll,et al.  Interference of engineered nanoparticles with in vitro toxicity assays , 2012, Archives of Toxicology.

[19]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[20]  M. Burton,et al.  The Photolysis of Azomethane. III. The Effect of Nitric Oxide and the Nature of the Primary Step1,2 , 1938 .

[21]  Lucienne Juillerat-Jeanneret,et al.  Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells. , 2012, The Biochemical journal.

[22]  Ivana Fenoglio,et al.  An integrated approach to the study of the interaction between proteins and nanoparticles. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[23]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[24]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[25]  Helinor Johnston,et al.  Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.

[26]  Maria Dusinska,et al.  Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. , 2012, Journal of environmental monitoring : JEM.

[27]  Andrew D Maynard,et al.  Nanotechnology: the next big thing, or much ado about nothing? , 2007, The Annals of occupational hygiene.

[28]  R. Janzer,et al.  Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines , 1992, In Vitro Cellular & Developmental Biology - Animal.

[29]  E. Teller,et al.  ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .

[30]  Pratim Biswas,et al.  Validation of an LDH assay for assessing nanoparticle toxicity. , 2011, Toxicology.